DotLab
Biotechnology ResearchNew York, United States2-10 Employees
DotLab is a small biotechnology company based in New York, United States, focused on women's health through diagnostic innovation. It is developing DotEndo, a diagnostic program for endometriosis that integrates AI and machine learning with clinical evaluation, supported by a multidisciplinary team. The company targets clinicians and patients dealing with endometriosis, aiming to improve diagnostic accuracy and personalized care. In 2019, DotLab announced a collaboration with Yale University to evaluate the performance of its test relative to laparoscopy across multiple clinical cohorts. The organization operates within the biotechnology research sector and seeks to advance diagnostic tools in women's health through data-driven approaches.